Correlation of FGF-23, iPTH, and Hcy levels together with other laboratory parameters in CKD HD patients may help us for earlier treatment strategies, try to slow patterns of renal failure, and minimize its impacts on the progression to ESRD. This evidence concerns the gene FGF23 and Renal insufficiency.